
All antibodies go through multi-dimensional assessment covering discovery, expression, purification and real-scenario application validation to ensure reliable overall performance.
Possess excellent target specificity and structural stability, avoiding false signals and performance attenuation during long-term biopharma testing.
Fully compatible with key workflows of biologic research, quality control and clinical translation, providing consistent high-quality tool support for the full drug development pipeline.

Payload-specific antibodies for ADC quantification and conjugate integrity QC.

High-affinity antibodies for therapeutic antibody PK/PD analysis, ADA assay development and immunogenicity assessment.

Cell markers for immune cell identification, ex vivo activation and expansion.

Specific antibodies targeting cell surface markers, multi-transmembrane proteins, inflammatory cytokines and neuronal proteins.

Ideal for PK and ADA assays, CAR expression detection, and other ligand-binding assay applications, enabling reliable bioanalysis throughout drug development.

Specifically recognize flexible G4S and 218 linker sequences for expression identification and molecular integrity QC of CARs, bispecific antibodies and fusion proteins.

His/Myc tag, fluorescent labeled and biotin antibodies supporting full workflows of recombinant protein identification, tracking, purification, IF and flow cytometry.

Comprehensive antibody panel covering SARS-CoV-2, influenza, monkeypox, RSV, herpes, rabies, dengue, Nipah, Hendra, Hantaan, Coxsackievirus and AAV.

Enabling VHH-based CAR detection, VHH antibody screening, and tLNP internalization assessment.
Supporting tLNP-mRNA internalization assessment and intracellular delivery evaluation.

Human/mouse IgG & IgG Fc secondary antibodies for nanobody characterization, isotyping and preclinical bioanalysis.

Human, mouse and cynomolgus IgG isotype controls covering all subtypes, wild-type and clinical Fc variants as negative references to eliminate non-specific background.

IHC antibodies enable the localization, qualitative, and quantitative analysis of antigens within tissue cells, effectively integrating morphological and functional studies.
End-to-end custom antibody development - covering anti-idiotype, IHC, flow cytometry, and diverse antibody formats. Efficient project delivery.
Inquire Now
Based on AI-designed antibody sequences, we provide full services from gene synthesis, high-throughput screening to antibody production and multi-dimensional functional validation.
Inquire Now
Five integrated platforms cover the full antibody workflow from discovery to validation, supporting development from lab-scale studies to commercial manufacturing.
A broad antibody portfolio supports ADC, cell therapy, virology and pathology research, including anti-idiotypic, anti-payload, IHC, secondary antibodies and isotype controls.
Custom antibody development and standardized reagents support target discovery, ADC QC, immunogenicity assays and biomarker analysis across biopharma R&D.
Rigorous QC ensures high purity, stable bioactivity and lot-to-lot consistency, with comprehensive validation data supporting research and preclinical studies.